1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-46-5-357
1997-05-01
2022-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/46/5/medmicro-46-5-357.html?itemId=/content/journal/jmm/10.1099/00222615-46-5-357&mimeType=html&fmt=ahah

References

  1. Russell P. K., Howson C. P. Vaccines against malaria: hope in a gathering storm. Washington, DC: National Academy Press; 1996
    [Google Scholar]
  2. Jones T. R., Hoffman S. L. Malaria vaccine development. Clin Microbiol Rev 1994; 7:303–310
    [Google Scholar]
  3. Sinnis P., Nussenzweig V. Preventing sporozoite invasion of hepatocytes. In Hoffman S. L. (ed) Malaria vaccine development: a multi-immune response approach Washington, DC: ASM Press; 199615–33
    [Google Scholar]
  4. Rodrigues M., Li S., Murata K. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol 1994; 153:4636–4648
    [Google Scholar]
  5. Stoute J. A., Slaovi M., Heppner D. G. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum. N Engl J Med 1997; 336:86–91
    [Google Scholar]
  6. Amador R., Aponte J. J., Patarroyo M. E. Development and field-testing of the synthetic SPf66 malaria vaccine. In Hoffman S. L. (ed) Malaria vaccine development: a multi-immune response approach Washington, DC: ASM Press; 1996229–248
    [Google Scholar]
  7. Alonso P. L., Smith T., Armstrong Schellenberg J. R. M. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1996; 344:1175–1181
    [Google Scholar]
  8. D’Alessandro U., Leach A., Drakeley C. Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 1995; 346:462–467
    [Google Scholar]
  9. Nosten F., Luxemburger C., Kyle D. E. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Lancet 1996; 348:701–707
    [Google Scholar]
  10. Holder A. A. Preventing merozoite invasion of erythrocytes. In Hoffman S. L. (ed) Malaria vaccine development: a multi-immune response approach Washington, DC: ASM Press; 199677–104
    [Google Scholar]
  11. Kaslow D. C. Transmission-blocking vaccines. In Hoffman S. L. (ed) Malaria vaccine development: a multi-immune response approach Washington, DC: ASM Press; 1996181–227
    [Google Scholar]
  12. Targett G. A. T. Malaria -advances in vaccines. Curr Opin Infect Dis 1995; 8:322–327
    [Google Scholar]
  13. Hoffman S. L., Franke E. D., Hollingdale M. R., Druilhe P. Attacking the infected hepatocyte. In Hoffman S. L. (ed) Malaria vaccine development: a multi-immune response approach Washington, DC: ASM Press; 199635–75
    [Google Scholar]
  14. Conway D. Natural selection on polymorphic malaria antigens and the search for a vaccine. Parasitology Today 1997; 13:26–29
    [Google Scholar]
  15. Aidoo M., Lalvani A., Allsopp C. E. M. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 1995; 345:1003–1007
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-46-5-357
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error